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Until recently, the initial changes in osteoarthritis 
have been considered to be essentially a mechanical degenerative 
process and beyond efforts at prevention or control. The se¬ 
quence of gross and microscopic changes in articular cartilage 
which occurs in this condition is well known. The hyaline car¬ 
tilage, normally a pearly grey, smooth and glistening substance, 
becomes opaque, dull and pitted with yellow discoloration. The 
small grooves and pits which have formed in these areas enlarge 
producing deep clefts and the tissue loses its resilience, upon 
which the nutrition of chondrocytes is dependent. There is a 
general paucity of cellular elements with occasional clusters 
of proliferating chondrocytes. Histologically the articular sur¬ 
face shows fibrillation with loss of mucopolysaccharide as evi¬ 
denced by an absence of metachromatic staining of these areas 
with toluidine blue. This process leads inevitably to erosion 
of the cartilage exposing the pain sensitive subchondral bene. 
At the margins of the articular surface spur formation takes place. 
These are initially cartilaginous, but become osseous by en- 
chondral ossification. Cartilaginous loose bodies or "joint mice" 
(1) 
are often found in the joint space. 
The biochemical alterations which parallel these changes 
are increasingly the subject of numerous investigations. In 1944, 
Hirsch, investigating the pathogenesis of chondromalacia of the 
patella, found that the chondroitin sulfate (CSA) content of the 
involved cartilage was often decreased in samples which grossly 
showed no fissures, Kellgren, in a review of the problem, 
proposed that a decrease in the polysaccharide content of carti- 

(2) 
lage resulted in a breaking up and disintegration of unsuoported 
(3) 
collagen fibrils by wear and tear. B. F. Matthews, investi¬ 
gating the collagen/CSA ratio in fibrillar cartilage from osteo- 
arthritic joints, found that the ratio was greater in fibriUated 
than in normal cartilage reflecting a loss of CSA of greater mag- 
(4) 
nitude than loss of collagen. 
The enzymatic degradation of chondromucoprotein (CMP) 
with splitting off of CSA may be involved in the biochemical 
changes noted. Trypsin and testicular hyaluronidase have been 
shown to decrease the viscosity of CMP solutions, but lysozyme 
(5) 
has no effect. Intravenous papain causes the degradation of 
CMP in vivo, resulting in loss of basophilic and metachromatic 
(6) 
staining of hyaline cartilage. Tsaltas has reported a de¬ 
pletion of CMP and CSA from rabbit cartilage after the adminis¬ 
tration of intravenous papain. The loss of CSA was found to be 
(7) 
greater than the CMP loss. Incubation of cartilage strips 
with bovine plasmin results in a liberation of considerable CSA 
into the incubation medium as compared to control samples and in- 
(8) 
cubation media to which antiplasminogen had been added. Bac- 
(9) 
terial enzymes which degrade CMP have also been reported. 
Recently Ziff et a1. have reported the enzymatic degradation of the 
CSA-protein complex by leukocytic and synovial extracts. Activity 
of the synovial extracts was clearly related to tissue content of 
polymorphonuclear leukocytes in these rheumatoid joints. (10) The 
decrease in ester sulfate content of articular cartilage strips 
incubated in Tyrode1s solution as a control was found to be greater 
than that produced by human plasmin during incubations of 15 hours 

(3) 
(11) 
duration reported by Chrisman et al. 
The latter findings raised the question of the pre¬ 
sence of an enzyme in human articular cartilage itself which 
could cause the degradation of the protein-CSA complex. It is 
the purpose of this paper to investigate the possible presence 
of such an enzyme in human articular cartilage by incubating CMP 
with cell free extracts of normal and pathological cartilage and 
measuring the reaction by viscometry. 
Methods 
Chondromucoprotein (CMP) was prepared from calf nasal 
cartilage according to the method of Shatton and Schubert. ^ ^ 
Solutions of varying concentration were prepared with saline - 
phosphate buffer, pH 7.0. 
Cell free extracts of surgical specimens were prepared 
in the following manner. The cartilage samples were weighed and 
thoroughly homogenized in 0.9N NaCl (1 gram to 45 ml.) in a Vir- 
tis-45 machine at 4°C. These homogenates were centrifuged at 
4000 RPM for 45 minutes. The cell free supernatants were re¬ 
tained for the incubations. 
The degradation of chondromucoprotein by these ex¬ 
tracts was studied by viscometry. Six ml. of 1% chondromucopro¬ 
tein and two ml. of each extract were incubated in Cannon-Fiske 
#100 viscometers at 37°C for three hours. Efflux time deter¬ 
minations were made at 0,5,10,15 and 30 minutes and at succeed¬ 
ing 30 minute intervals to three hours. Per cent initial rela¬ 
tive viscosity was calculated by the formula; 7.initial relative 
viscosity = to-tx where tQ is the efflux time at the initial read- 
tx 

(4) 
ing and tx is the efflux time at any succeeding determination. 
The enzymatic nature of the reaction was investigated 
in several ways. Trace amounts of various enzyme inhibitors in¬ 
cluding HgCl2> NaCN and IAA were added to the reaction mixture. 
The extracts were heated to 60°C for 10 minutes before incuba¬ 
tion with chondromucoprotein. Finally the concentration of CMP 
was varied from 0.75 to 1.5% and its effect on reaction rate re¬ 
corded . 
A study of the reaction products was also carried out. 
After the reaction was terminated by freezing, the reaction mixture 
was filtered through an ultra fine fritted glass bacterial filter 
(!,Pyrex'! Brand Chemical Glass, #33990, UF porosity) to remove 
(12) 
protein. The filtrate was spotted (0.04ml.) on #1 Whatman 
paper and electrophoresis carried out with chondroitin sulfate 
A and C, prepared from calf nasal septum and steer tendon respec¬ 
tively by the method of Einbinder and Schubert, as control spots. ^ 
The filtered reaction mixture was also analyzed for the presence of 
amino acids and sugars by paper chromatography with a filtrate of 
17. CMP solution incubated alone for three hours with buffer ser¬ 
ving as a control. Chromatographic technique for sugars involved 
spotting of 50 microliters on Whatman #4 paper and a solvent pre¬ 
pared as follows: 600ml, n-butanol, 165ml. ethanol, 400ml. dis¬ 
tilled water and 10ml. NHg (3.2ml. cone. NH^ (w/v) made up to 100 
ml. with water). Chromatography was run for 40 hours and sugars 
were stained by a process involving the use of aniline - phthalate 
spray and heating to 100 - 105 C for 10 minutes. Identification 
of amino acids involved a two phase process in which 50 micro- 
. ) 
. ) 
(5) 
liters were spotted on Whatman #4 paper. Water saturated phenol 
with 6-8 drops of concentrated ammonia and a trace of NaCN was 
used as solvent in the first phase. Second phase solvent was pre¬ 
pared from 600 ml. collidine, 600 ml. 2,4 - lutidine and 1000 ml. 
distilled water with 6-8 drops of diethylamine added. Paper was 
stained with 0.157. ninhydrin in acetone. 
Results 
I Effect of Extracts on Chondromucoprotein Viscosity 
CMP in 17. solution was incubated with neutral saline- 
phosphate buffer for three hours as a control. There was no de¬ 
crease in the viscosity of the solution. 
Six normal cartilage extracts showed an average vis¬ 
cosity reducing activity of 6.4% with a range of 1.9 to 10.9% 
(table 1). 
Table 1 
Viscosity Reducing Activity of Normal Cartilage Extracts 
sample # age % decrease in relative viscosity 
(3 hours) 
1 17 9.3 
3 18 2.4 
7 9 7.7 
8 7 1.9 
17 17 10.9 
22 30 6.2 
Eight pathological samples were obtained from osteo- 
arthritic joints. Of these, five were from fibrillated areas and 

(6) 
three were spur cartilage. The five chondromalacic samples showed 
an average viscosity reducing activity of 9.9% with a range of 2.6% 
to 19.1%. The spur cartilage on the other hand showed an average 
viscosity reducing activity of 3.1% with a range of 2.7% to 3.6%. 
(table 2) Although the chondromalacic samples showed an activity 
which was significantly greater than that of spur cartilage, they 
did not show much greater activity than the normal samples. 
Table 2 
Viscosity Reducing Activity of Hypertrophic Arthritic Cartilage 
Extracts 
ample # source age % decrease in relative viscosity 
(3 hours) 
2 C * 35 19.1 
6 C 20 2.6 
14 c 30 13.0 
15 c 50 9.6 
20 c 19 5.4 
4 s * 62 2.7 
5 s 27 3.3 
18 s 46 3.6 
* C = Chondromalacia; * S * Spur cartilage 
Several other tissues were studied including loose bodies 
and one chondrosarcoma. Extracts of three loose bodies showed an 
average viscosity reducing activity of 3.1. The chondrosarcoma ex¬ 
tract had a 17.1% viscosity reducing activity in three hours (table 3). 

(7) 
Table 3 
Viscos ity Reducing Activity of Other Pathological Extracts 
Sample Source 7 t decrease in relative 
(3 hours) 
viscosity 
9 Loose Bodies 3.8 
24 Loose Bodies 2.8 
36 Loose Bodies 2.7 
11 Chondrosarcoma 17.1 

(8) 
II Enzyme Characteristics. 
The most active osteoarthritic extract was used in a 
series of experiments to demonstrate the enzymatic nature of the 
reaction. Enzyme inhibitors in trace amounts were added to the 
reaction mixture, NaCN and HgCl2 reduced the activity of the ex¬ 
tract by about 507o. IAA, however, had no effect. Heating of the 
extract prior to incubation with CMP destroyed its activity al¬ 
most completely (figure 1). 
Figure 1 
Effect of Heat, HgClp and NaCN on viscosity reducing 
activity of cell free human cartilage extracts. 

(9) 
The effect of changes in enzyme concentration, pH and 
temperature have not been studied. However, the effect of change 
in substrate concentration was studied by varying the concentra¬ 
tion of chondromucoprotein from 0,75 to 1,25% while holding enzyme 
concentration constant. As is illustrated in figure 2 an increase 
in chondromucoprotein concentration resulted in a corresponding in¬ 
crease in reaction rate, a pattern typical of any chemical reaction. 
Figure 2 
Effect of changes in CMP concentration on rate of 
viscosity reduction by cell free human cartilage 
extracts. 

(10) 
The reaction rate using 1.5% chondroraucoprotein was identical to 
that of the 1.25% reaction suggesting that the reaction had reached 
a maximum velocity which could not be changed by further increase 
in substrate concentration. This phenomenon is characteristic of 
those chemical reactions which are enzymatic in nature and is due 
to the limited rate of formation of the enzyme - substrate complex. 
Further study of this problem was curtailed by our inability to 
prepare a suitable solution of chondroraucoprotein with a concentra¬ 
tion greater than 1.5%. We feel that the evidence is sufficient to 
indicate that the decrease in relative viscosity of chondromucopro- 
tein solutions which we have observed is due to enzyme activity. 
Ill Analysis of Reaction Products 
The problem of site of action of the enzyme or emzymes 
involved in the process of chondromucoprotein degradation was 
approached by an analysis of reaction products. There were three 
main possibilities: 1) the enzyme was proteolytic in nature, de¬ 
grading the protein to amino acids and peptides, 2) it was a 
chondroitinase degrading the CSA portion of the complex; or, 3) it 
was an enzyme splitting off chondroitin sulfate intact from the 
protein. 
After ultrafiltration of the reaction mixture to remove 
residual protein, the filtrate was electrophoresed with chondroitin 
sulfate A and C as control spots and also subjected to paper choma- 
tographic analysis. Electrophoresis of the filtrate revealed a 
large metachromatic spot with a mobility identical to that of 
chondroitin sulfate C, but slightly less than that of chondroitin 
sulfate A, figure 3 and 4. 

(11) 
Figure 3 
Ch-S04 c 
UNKNOWN 
Electrophoresis of protein free filtrate of reaction mixture 
and chondroitin sulfate C. Acetate buffer, pH 4.3. 
Figure 4 
Electrophoresis of protein free filtrate of reaction mixture 
and chondroitin sulfate A. Acetate buffer, pH 4,3. 
' ) 
(12) 
As the size and metachromaticity of the spot were notable, 
it was felt that undegraded CSA was a major reaction product. Chroma¬ 
tography was carried out to investigate the possibility that there 
might be some mucopolysaccharide degradation or proteolytic activity 
present in the cartilage extracts. Neither amino acids, peptides 
or sugars were demonstrable in the filtrate by this method. It is 
felt that CSA Is being split from the protein at or very near the 
protein-chondroitin sulfate bond releasing CSA intact or perhaps 
with a small polypeptide attached. 
Discussion 
Although the intermediate steps in the synthesis of the 
CSA molecule through the UDPG system and nactive" sulfate have been 
well demonstrated, (14, 15, 16,) the sequence of steps by which the 
ground substance of mammalian cartilage is degraded is poorly under¬ 
stood, In approaching this problem it is necessary to determine 
the initial biochemical changes which occur in normal and patholo¬ 
gical states. There is neither histological nor biochemical evid¬ 
ence that degradation of collagen is involved in the early steps of 
this process. There has been no demonstration of a collagenase 
which is functional at neutral pH in mammalian tissues. The work 
of Matthews has demonstrated a loss of CSA rather than collagen in 
fibrillated cartilage from osteoarthritic joints. The problem then 
clearly involves the catabolism of the other major component of the 
ground substance, chondromucoprotein. 
There are a variety of known enzymes which are capable of 
degrading CMP, but which can not logically be indicted as the agent 
involved in the degeneration of the ground substance in osteoarthri- 

(13) 
tis. The various plant and bacterial enzymes, of which papain is 
the most noteworthy, simply are not present in the sterile joints. 
There are insufficient polymorphonuclear leukocytes involved in 
the osteoarthritic process to incriminate the leukocytic enzyme 
which Ziff has proposed as a factor in the destruction of arti¬ 
cular cartilage in rheumatoid arthritis. The proposal has been 
made that plasmin, a proteolytic agent involved in fibrinolysis, 
may be involved in CMP catabolism in the arthritic joint. Cer¬ 
tainly this enzyme could gain access to the joint surface as a 
result of trauma and hemorrhage into the synovial space. It has 
been recently shown that plasmin can indeed degrade CMP in an 
np\ 
isolated system of enzyme and CMP solution. ' Lack's investi¬ 
gation of the problem by incubation of cartilage strips with plas¬ 
min demonstrated a considerable liberation of CSA as compared to 
control incubations or those to which antiplasminogen had been added 
However, repeated attempts to demonstrate degenerative changes in 
vivo by multiple injections of plasmin into intact and traumatized 
(11) 
animal joints have been singularly unproductive. v This paper, 
however, presents evidence for the presence of an enzyme in nor¬ 
mal and osteoarthritic cartilage which may be the agent causing 
the initial steps in CMP catabolism. 
Having demonstrated such an enzyme in both normal and 
pathological cartilage, the next question which demands a solution 
is that of the site of action of this enzyme. There are theoreti¬ 
cally four potential sites for enzymatic cleavage of this com¬ 
pound whose structure presumably is a linear arrangement of CSA 
(17) 
complexes bound to protein. s These include 1) proteolysis of 
(8) 
r \ 
(14) 
Schubert's protein, 2) depolymerization or further degradation of 
the polysaccharide, 3) chondrosulfatase activity and 4) cleavage 
of the protein to polysaccharide bond. 
Analysis of osteoarthritic joint fluids reveals fully 
polymerized CMP staining metachromatically and particulate cartilage 
containing collagen. Two studies involving an analysis of joint 
fluids have shown no significant difference in the glucosamine/ 
galactosamine ratio in normal and pathological joint fluids with 
the exception of one patient in each series who showed an elevated 
galactosamine. Repeated attempts to demonstrate chondro¬ 
sulfatase activity in cell-free extracts of mammalian connective 
and parenchymal tissues (costal cartilage, cornea, subcutaneous 
tissue, liver, kidney and spleen) by in vitro incubation with S 
labeled chondroitin sulfate have been singularly unproductive.^'^ 
Studies of the fate of the SO4 portion subcutaneously injected 
chondroitin sulfate labeled with S ^ ' and 6F 3 metabolism 
utilizing cartilage strip incubation techniques have, how¬ 
ever, been suggestive of the presence of such an enzyme. Recent 
work by Thomas et al, comparing the effects of large doses of 
vitamin A and of papain has shown a similarity of observable altera¬ 
tion in the cartilage matrix - loss of metachromaticity with an 
increase of a substance in serum presumed to be chondroitin sul¬ 
fate because of its turbidimetric characteristics after treatment 
with hexaminecobaltic chloride and a loss of S from articular 
and epiphyseal cartilage.^2) The suggestion was made that vitamin 
A produced these changes by activation of a proteolytic enzyme in 
cartilage which had an action similar to papain. The enzyme which 
has been demonstrated by our work could be responsible for the 
change produced by large doses of vitamin A. Indeed an intra- 

(15) 
cellular protease with an optimum pH of 3 has been demonstrated 
in normal chondrocytes which produces changes in the matrix closely 
resembling those produced by excess vitamin A. 
There have been several interesting studies which have 
investigated the dynamic biochemical changes in osteoarthritic 
cartilage, Collins and McElligott have shown an increasing avidity 
for SO^ in cartilage strips with increasing grade of severity of 
osteoarthritic changes in the strips and have noted an increase in 
mucopolysaccharide content of the matrix surrounding all clumps in 
fibrillated cartilage. McElligott and Potter have reported a 
50% greater uptake of S J by papain treated rabbits as compared to 
controls.These changes, which are interpreted as an attempt at 
regeneration in injured tissues, are not surprising in view of the 
demonstration by Crelin and Southwick of mitosis in adult cartilage 
in response to a pathological stimulus. ^6) McElligot and Potter 
suggested that the overall loss of chondroitin sulfate from the 
osteoarthritic cartilage is due to the "poor binding power" of the 
matrix. The enzyme which we have demonstrated in human cartilage 
may well be responsible for the initial steps in the catabolism 
of matrix mucopolysaccharide. Although we have not demonstrated 
a markedly higher activity in osteoarthritic samples as compared 
to normal controls, the highest activities recorded were in these 
samples. Fibrillated cartilage showed a much greater activity than 
either spur or loose body cartilage. The chondrosarcoma was the 
most active of all samples perhaps reflecting a markedly greater 
metabolic turnover. We can only infer that this enzyme is re¬ 
sponsible for the degenerative changes noted. 

(16) 
Recent work has raised the possibility that this pro¬ 
cess may be reversible. Chrisman and Southwick in a study of the 
effects of adjuvants on SO4 metabolism have noted that incubation 
of cartilage strips in a medium containing hydluronic acid or 
35 
chondroitin sulfate increased S O4 incorporation and total ester 
sulfate content of the tissue. Incubation with other adjuvants 
produced a catabolic effect with decrease in total ester sulfate 
35 (271 in spite of S pickup,' J Recent experiments in this labora¬ 
tory investigating the effects of salicylate and hydrocortisone 
35 
on the clearance of CS A from rabbit knee joints have shown a 
diminished rate of clearance of labeled material from treated 
as compared to control animals. Perhaps these agents pro¬ 
duce a partial reversal or retardation of the degradation of chon- 
dr omucoprotein by increasing the concentration of reaction pro¬ 
ducts in the joint fluid. 
Conclusion 
An enzyme has been demonstrated in human cartilage which 
is capable of degrading chondromucoprotein by splitting off chon¬ 
droitin sulfate intact. The levels of activity of this enzyme in 
normal, osteoarthritic, loose body, and chondrosarcomatous carti¬ 
lage have been investigated. The dynamic biochemical changes in 
osteoarthritic cartilage are discussed with reference to the 
possible role of this enzyme in hypertrophic arthritis. 
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